Demonstration of a chronic myelogenous leukemia clone in acute myelogenous leukemia
In the present study, we report a case of a 58-year
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
In the present study, we report a case of a 58-year
tumour cells target or originate from, like brain cancer mostly affects brain. Similarly, chronic myelogenous leukemia is also a type of cancer that occurs in bone marrow of the body ... present inside bones and it is…
Chronic Myelogenous Leukemia (CML) is a cancer of the white blood cells. It develops, when a hematopoietic stem cell in the bone marrow acquires a Philadelphia (Ph) chromosome carrying ... played by the two isoforms in…
Chronic Myelogenous Leukemia (CML) is a myeloproliferative disorder characterized by the appearance of abnormal proliferation of white blood cells in the Philadelphia chromosome. Current drugs target ABL kinase may have…
Acute Myelogenous Leukemia (AML) is an aggressive hematologic malignancy characterized by clonal proliferation of myeloid precursors with impaired differentiation. This review provides a comprehensive overview of AML…
very few cases. We report a rare case of multiple myeloma and chronic myelogenous leukemia co-existence in a 55-year-old male initially presenting with granulocytosis and splenomegaly. Subsequent ... with BCR/ABL FISH…
allogeneic haematopoietic cell transplantation (HCT) is related to improved outcomes for patients with chronic Myelogenous leukaemia during this written account study, we have a tendency to analyzed clinical outcomes
most lethal of the cancers in the modern era. Out of all Leukaemia, Acute Myelogenous Leukaemia (AML) is the most notorious. The treatment regime being expensive & toxic
blood. This study aimed to measurement the hypercoagulability state in Sudanese patients with acute myelogenous leukemia in Khartoum state between November 2015 and April 2016. The study included 80 individuals ... them…
amplifying cells, and ultimately differentiated cancer cells. The model can be applied to Acute Myelogenous Leukemia (AML), a hematopoieticderived cancer. A single tumor population of AML is composed
Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm characterized by abnormal hyperplasia of granulocytes. Though not one of the common signs and symptoms, extramedullary hematopoiesis (EMH) can be…
prognosis for patients with Chronic Myelogenous Leukemia (CML) in Blastic Crisis (BC) is poor, with a median survival of only 3-6 months. Blast crisis (BC) is highly refractory
revealed leukemia cutis with underlying atypical infiltrate contained atypical myeloid forms consistent with acute myelogenous leukemia (AML). His skin biopsy provided the first evidence of progression to AML. AML…
trainee needs to know in the epidemiology, clinical presentation, evaluation and management of acute myelogenous leukemia allow for adapting these achievement goals into a specific set of skills that match
cytogenetic abnormality found in fewer than 5% of pediatric and adult cases of acute myelogenous leukemia (AML). The outcomes of t(6;9) AML are generally poor, with low five
Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm that originates in an abnormal pluripotent bone marrow stem cell and is defined by the presence
PTEN before and after hematopoietic stem cell transplantation (HSCT) in pediatric patients with acute myelogenous leukemia (AML) and evaluate if any potential alterations could predict relapse after HSCT. Procedure…
myelodysplastic syndrome (MDS) evolves into acute myelogenous leukemia (AML), it is generally believed that these patients if they survive long enough will eventually transform and in the past named
Although not all patients with myelodysplastic syndrome (MDS) evolve into acute myelogenous leukemia (AML), it is generally believed that these patients if they survive long enough will eventually transform
Modern clinical therapy of chronic myeloid leukemia with TKIs is highly efficacious
investigate the effect of treatment with resveratrol combined with imatinib mesylate on human chronic myelogenous leukemia K562 cell growth inhibition and apoptosis, in vitro cultured human chronic myelogenous leukemia…
Chronic Myeloid Leukaemia (CML) is a haematological malignancy that is identified by
We present a case of a 48-year-old male who presented
For authors and organisers
Find the right journal for your paper and submit your manuscript.